Hi, what are you looking for?
Jewish Business News
Search results for "Copaxone"
Business
Copaxone is a brand name for the medication glatiramer acetate. It's primarily used to treat relapsing forms of multiple sclerosis (MS)
Court
The state asserts that Teva infringed intellectual property rights during the development of the multiple sclerosis medicine with a longer gap between doses. The...
Court
The UK court ruled in favor of Mylan and its Dutch partner Synthon and canceled all of Teva's patents on Copaxone 40 mg in...
Business
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) announced today that the the Japanese Ministry of Health, Labour and Welfare has approved once-daily...
Business
Teva says it will seek ‘further appellate review’
Business
Teva’s American Depositary Receipts rose 2.2 percent to $63.31, giving it a market value of just under $54 billion.
Business
Copaxone’s patent remains in force at least until the Federal Circuit Appeals Court reconsiders the case. The rivals of Teva Pharmaceutical Industries Ltd. (NYSE:...
Court
The ruling means Teva’s flagship multiple sclerosis treatment’s patent remains valid until September 2015. The US Supreme Court has ruled in favor of...
Business
– “We are upgrading our recommendation for Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) from “Market perform” to “Market outperform” with a target...
Business
– The decision gives Teva more time to transfer patients to its better patent protected double dosage Copaxone. – Teva Pharmaceutical Industries Ltd. (NYSE:...